Alzheimer’s disease (AD) is characterized by progressive memory decline and emotional and neuropsychiatric symptoms associated with accumulation of amyloid-β (Aβ) plaques and tau-containing neurofibrillary tangles (NFTs)1. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.